| Log in

Japanese Mitsui To Buy 5% In Arch Pharma For Rs 65Cr

23 September, 2010

Japanese company Mitsui & Co Ltd is set to acquire 5% stake in major pharmaceuticals ingredient manufacturer, Arch Pharmalabs Limited. Mitsui has entered into an agreement with Arch Pharmalabs to acquire newly subscribed shares of approximately 5% of Arch at around Rs 65 crore.

Arch Pharmalabs, one of the leading chemical intermediate and active pharmaceuticals ingredient (API) manufacturers, is currently supplying its products to numerous leading multinational pharmaceutical companies based in the US, Europe and the Middle East, for drugs indicated for hypertension, hyperlipidemia, antibiotics and cancer amongst others. Arch Pharmalabs Limited has revenue of approximately Rs 1,186 crore as on March 2010.

Post-Mitsui’s allotment, the promoter group will hold 34.27% in Arch Pharma, PE fund holds 43.28%, Mitsui 5.25% and others 17.2%. ICICI Venture invested in Arch Pharma through its India Advantage Fund Series I and II while other investors include South Asian Regional Apex Fund, a VC fund managed by IL&FS Investment Managers Ltd  and Swiss Technology Venture Capital Fund, managed by BTS Investment Advisors Pvt. Ltd.

Through this investment, Mitsui intends to strengthen the contract manufacturing organization business platform. Further this investment illustrates Mitsui’s recognition of India as having a huge potential for manufacturing pharmaceutical chemical intermediates and APIs and the growing market demand in the Asia Pacific region, said a statement from Mitsui.


Leave Your Comment
News Roundup: Mitsui & Co buys additional 25% stake in Arch Pharmalabs for Rs 372Cr

News Roundup: Mitsui & Co buys additional 25% stake in Arch Pharmalabs for Rs 372Cr

TEAM VCC 5 years ago
Mitsui & Co buys additional 25% stake in Arch Pharmalabs for Rs 372Cr:&#...
Mitsui picks up 30% in plumbing major Toto's India unit for $10.9M

Mitsui picks up 30% in plumbing major Toto’s India unit for $10.9M

Madhav A Chanchani 5 years ago
Japanese conglomerate Mitsui & Co., Ltd is picking a 30 per cent stake in...
Tata Capital Healthcare Fund invests in Marck Biosciences; IFCI part-exits

Tata Capital Healthcare Fund invests in Marck Biosciences; IFCI part-exits

Madhav A Chanchani 5 years ago
A private equity fund, managed by Tata Capital and focused on healthcare &...
No Comments

Japanese Mitsui To Buy 5% In Arch Pharma For Rs 65Cr

Powered by WordPress.com VIP